Rosiglitazone, medical reversal, and back to basics for diabetes.
作者信息
Prasad Vinay
机构信息
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
出版信息
Am Fam Physician. 2014 Sep 15;90(6):368, 370.
PMID:25251229
Abstract
摘要
相似文献
1
Rosiglitazone, medical reversal, and back to basics for diabetes.罗格列酮、医学逆转与糖尿病回归基础
Am Fam Physician. 2014 Sep 15;90(6):368, 370.
2
US regulators relax restrictions on rosiglitazone.美国监管机构放宽对罗格列酮的限制。
BMJ. 2013 Nov 28;347:f7144. doi: 10.1136/bmj.f7144.
3
FDA panel advises easing restrictions on rosiglitazone.美国食品药品监督管理局专家小组建议放宽对罗格列酮的限制。
BMJ. 2013 Jun 10;346:f3769. doi: 10.1136/bmj.f3769.
4
How doctors practice evidence-based medicine.医生如何实践循证医学。
J Eval Clin Pract. 2013 Feb;19(1):44-9. doi: 10.1111/j.1365-2753.2011.01765.x. Epub 2011 Aug 24.
5
Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow.令人震惊的消息。糖尿病药物文迪雅正面临抨击：你应该了解的情况。艾弗里·科马罗采访报道
US News World Rep. 2007 Jun 4;142(20):64.
6
Efficacy and safety of a combination of metformin and rosiglitaone in patients with type 2 diabetes mellitus--a postmarketing study.二甲双胍与罗格列酮联合用药治疗2型糖尿病患者的疗效与安全性——一项上市后研究
J Indian Med Assoc. 2003 Feb;101(2):113-4, 123.
7
In brief: rosiglitazone (Avandia) unbound.简而言之：罗格列酮（文迪雅）游离状态。
Med Lett Drugs Ther. 2014 Feb 3;56(1435):12.
8
Thiazolidinediones in type 2 diabetes: a cardiology perspective.噻唑烷二酮类药物在2型糖尿病中的应用：心脏病学视角
Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2.
9
Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.单纯饮食、胰岛素、磺脲类药物、二甲双胍和噻唑烷二酮类药物与糖尿病患者冠状动脉疾病严重程度的关联。
Am J Ther. 2006 Sep-Oct;13(5):400-3. doi: 10.1097/01.mjt.0000208276.65249.1b.
10
[Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].吡格列酮可保护2型糖尿病患者免受心肌梗死和中风的侵害。
MMW Fortschr Med. 2007 Aug 2;149(31-32):52-3.
引用本文的文献
1
Reversal and Remission of T2DM - An Update for Practitioners.2 型糖尿病的逆转与缓解——临床医生的最新进展。
Vasc Health Risk Manag. 2022 Jun 14;18:417-443. doi: 10.2147/VHRM.S345810. eCollection 2022.
Zotero 插件